Showing results (341-350 of 410) with videos related to

Sort By:
Pageof 41
Frontiers in Cardiovascular Medicine|January 3, 2022
Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial InfarctionXiaolin Zhang, Minghui Cheng, Naijing Gao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 19, 2022
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary interventionXin Zhao, Sicong Ma, Yi Kang, et al.
Frontiers in Cardiovascular Medicine|December 30, 2021
Trends in Bleeding Events Among Patients With Acute Coronary Syndrome in China, 2015 to 2019: Insights From the CCC-ACS ProjectXiao Wang, Guanqi Zhao, Mengge Zhou, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2018
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trialBo Xu, Yuejin Yang, Yaling Han, et al.
Archives of Cardiovascular Diseases|February 21, 2025
Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet countYang Zhang, Yongchen Hao, Jun Liu, et al.
Journal of the American College of Cardiology|October 17, 2015
Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China TrialRunlin Gao, Yuejin Yang, Yaling Han, et al.
Pageof 41